SCHEMBL6525600

SCHEMBL6525600

CCOCC(N)c1nc2cc(Cl)ccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.42
SCN10A Q9Y5Y9 6/20 0.40
CYP1A2 P05177 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37
S1PR4 O95977 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR5 Q9H228 1/20 0.37
HRH4 Q9H3N8 1/20 0.36
ROCK2 O75116 2/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
AAK1 Q2M2I8 4/20 0.36
KDM4E B2RXH2 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5110751 1.00 TAAR1 (0.42) TAAR1SCN10ACYP1A2LOXL2S1PR4
SCHEMBL4162306 0.88 TAAR1 (0.43) TAAR1SCN10ACYP1A2HRH4ROCK2
SCHEMBL583539 0.88 TAAR1 (0.43) TAAR1SCN10ACYP1A2HRH4ROCK2
SCHEMBL1479674 0.88 TAAR1 (0.43) TAAR1SCN10ACYP1A2HRH4ROCK2
SCHEMBL580331 0.86 TAAR1 (0.46) TAAR1SCN10ACYP1A2LOXL2S1PR4
SCHEMBL5110667 0.83 SCN10A (0.56) TAAR1SCN10ACYP1A2S1PR4S1PR1
SCHEMBL6529465 0.83 TAAR1 (0.36) TAAR1SCN10ACYP1A2LOXL2HRH4
SCHEMBL5110665 0.83 TAAR1 (0.36) TAAR1SCN10ACYP1A2LOXL2HRH4
SCHEMBL4166302 0.83 TACR1 (0.47) TAAR1SCN10AROCK2KDM4ERAB9A
SCHEMBL5103917 0.83 TACR1 (0.47) TAAR1SCN10AROCK2KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575925-A1 NOVEL CARBOXAMIDES, THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2005-09-21 EP disclosed
WO-2004056784-A1 NOVEL CARBOXAMIDES, THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-08 WO disclosed